Small molecule mediated upregulation of G3BP1 as a therapy for ALS

Ended Project Grant Awarded Last action

Award ID
HT94252310262
Recipient
Awarding agency
Obligated
$625,549

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Small-molecule-mediated upregulation of G3BP1 as a therapy for ALS. This modification 1. Extends the POP by 12 months. Technical and financial reporting shall… $0
Original award $625,549

Quick answers

Who received award HT94252310262?

HT94252310262 was awarded to Novation Pharmaceuticals Inc. by Defense Health Agency (Department of Defense) on April 1, 2023.

How much is award HT94252310262 worth?

$625,549 has been obligated on HT94252310262.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login